Farallon Capital Management 13F holdings, Q4 2020
Holdings as of December 31, 2020 · filings on SEC EDGAR · latest filing →
Farallon Capital Management disclosed 134 US equity positions worth $16.1bn in its Q4 2020 13F filing. The largest position was IQV at 4.5% of the reported book, followed by GOOG and TMUS. Against the Q3 2020 filing, it opened 9 new positions, added to 17 and reduced 13 among the top 50 holdings.
What did Farallon Capital Management own in Q4 2020? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q3 2020 |
|---|---|---|---|---|---|---|---|
| 1 | IQV IQVIA HLDGS INC | Healthcare | 4.5% | $724.5m | 4,043,506 | 15% | added |
| 2 | GOOG ALPHABET INC | Communication Services | 3.9% | $632.6m | 361,094 | -0% | held |
| 3 | TMUS T-MOBILE US INC | Communication Services | 3.3% | $532.5m | 3,949,181 | 9% | added |
| 4 | TMO THERMO FISHER SCIENTIFIC INC | Healthcare | 3.2% | $519.0m | 1,114,248 | 2% | added |
| 5 | V VISA INC | Financial Services | 3.0% | $487.4m | 2,228,104 | 30% | added |
| 6 | AON AON PLC | Financial Services | 3.0% | $479.9m | 2,271,514 | 29% | added |
| 7 | BSX BOSTON SCIENTIFIC CORP | Healthcare | 3.0% | $475.9m | 13,238,319 | 60% | added |
| 8 | FIS FIDELITY NATL INFORMATION SV | Technology | 2.8% | $445.5m | 3,149,118 | -0% | held |
| 9 | ARMK ARAMARK | Industrials | 2.6% | $424.2m | 11,023,949 | – | new |
| 10 | CNC CENTENE CORP DEL | Healthcare | 2.6% | $411.2m | 6,850,000 | -3% | reduced |
| 11 | ELV ANTHEM INC | Healthcare | 2.5% | $409.4m | 1,275,000 | 0% | held |
| 12 | MSFT MICROSOFT CORP | Technology | 2.4% | $391.1m | 1,758,168 | 14% | added |
| 13 | WAB WABTEC | Industrials | 2.3% | $365.8m | 4,997,371 | -8% | reduced |
| 14 | XILINX INC | 2.2% | $362.4m | 2,556,000 | – | new | |
| 15 | CHTR CHARTER COMMUNICATIONS INC N | Communication Services | 2.2% | $361.8m | 546,931 | -25% | reduced |
| 16 | ALXN ALEXION PHARMACEUTICALS INC | 2.2% | $351.1m | 2,246,900 | – | new | |
| 17 | NYT NEW YORK TIMES CO | Communication Services | 2.1% | $338.9m | 6,545,329 | -8% | reduced |
| 18 | XLRN ACCELERON PHARMA INC | 2.1% | $332.6m | 2,600,000 | 0% | held | |
| 19 | RTX RAYTHEON TECHNOLOGIES CORP | Industrials | 2.0% | $324.8m | 4,542,306 | – | new |
| 20 | META FACEBOOK INC | Communication Services | 2.0% | $315.2m | 1,154,005 | -25% | reduced |
| 21 | CRM SALESFORCE COM INC | Technology | 1.9% | $313.6m | 1,409,045 | 102% | added |
| 22 | TIFFANY & CO NEW | 1.9% | $300.6m | 2,287,000 | 0% | held | |
| 23 | SHW SHERWIN WILLIAMS CO | Basic Materials | 1.8% | $286.1m | 389,366 | -4% | reduced |
| 24 | IOVA IOVANCE BIOTHERAPEUTICS INC | Healthcare | 1.7% | $278.4m | 6,000,000 | 1% | added |
| 25 | FATE FATE THERAPEUTICS INC | Healthcare | 1.7% | $272.8m | 3,000,000 | -4% | reduced |
| 26 | AVGO BROADCOM INC | Technology | 1.7% | $272.8m | 622,995 | – | new |
| 27 | BX BLACKSTONE GROUP INC | Financial Services | 1.6% | $252.2m | 3,891,886 | 2% | added |
| 28 | EXEL EXELIXIS INC | Healthcare | 1.4% | $220.8m | 11,000,000 | 2% | added |
| 29 | NEW ORIENTAL ED & TECHNOLOGY | 1.3% | $214.5m | 1,154,300 | -16% | reduced | |
| 30 | WORK SLACK TECHNOLOGIES INC | 1.3% | $207.5m | 4,912,300 | – | new | |
| 31 | WTW WILLIS TOWERS WATSON PLC LTD | Financial Services | 1.3% | $202.8m | 962,500 | 1825% | added |
| 32 | IPHI INPHI CORP | 1.2% | $199.0m | 1,239,800 | – | new | |
| 33 | BABA ALIBABA GROUP HLDG LTD | Consumer Cyclical | 1.2% | $198.6m | 853,300 | 39% | added |
| 34 | MIRATI THERAPEUTICS INC | 1.2% | $192.2m | 875,000 | 0% | held | |
| 35 | HLT HILTON WORLDWIDE HLDGS INC | Consumer Cyclical | 1.1% | $182.5m | 1,640,437 | 6% | added |
| 36 | QGEN QIAGEN NV | Healthcare | 1.1% | $172.1m | 3,256,771 | – | new |
| 37 | TRU TRANSUNION | Financial Services | 1.1% | $172.1m | 1,734,082 | -4% | reduced |
| 38 | ASND ASCENDIS PHARMA A/S | Healthcare | 1.0% | $166.8m | 1,000,000 | -20% | reduced |
| 39 | HWM HOWMET AEROSPACE INC | Industrials | 0.9% | $139.6m | 4,891,479 | -32% | reduced |
| 40 | MXIM MAXIM INTEGRATED PRODS INC | 0.8% | $136.7m | 1,542,400 | 25% | added | |
| 41 | APELLIS PHARMACEUTICALS INC | 0.8% | $130.1m | 2,275,000 | 0% | held | |
| 42 | ABBV ABBVIE INC | Healthcare | 0.8% | $123.2m | 1,150,000 | -73% | reduced |
| 43 | AMYRIS INC | 0.7% | $108.1m | 17,500,000 | 25% | added | |
| 44 | SRPT SAREPTA THERAPEUTICS INC | Healthcare | 0.6% | $102.3m | 600,000 | 0% | held |
| 45 | MOMO INC | 0.6% | $93.5m | 110,077,000 | 6% | added | |
| 46 | PCG PG&E CORP | Utilities | 0.6% | $90.9m | 7,292,042 | 0% | held |
| 47 | SG7 SAGE THERAPEUTICS INC | 0.6% | $90.8m | 1,050,000 | 0% | held | |
| 48 | PLAYA HOTELS & RESORTS NV | 0.6% | $89.2m | 14,994,867 | -51% | reduced | |
| 49 | LU LUFAX HOLDING LTD | Financial Services | 0.5% | $76.1m | 5,357,750 | – | new |
| 50 | ENTA ENANTA PHARMACEUTICALS INC | Healthcare | 0.5% | $74.7m | 1,775,000 | 0% | held |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.